サンプル依頼リスト カート
  • English
  • Korean
市場調査レポート
商品コード
1375116

北米のバイオ医薬品向け凍結乾燥サービス市場の2028年までの予測- 地域別分析- サービスタイプ別、エンドユーザー別

North America Lyophilization Services for Biopharmaceuticals Market Forecast to 2028 - COVID-19 Impact and Regional Analysis - by Service Type and End User
出版日: | 発行: The Insight Partners | ページ情報: 英文 101 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.36円
北米のバイオ医薬品向け凍結乾燥サービス市場の2028年までの予測- 地域別分析- サービスタイプ別、エンドユーザー別
出版日: 2023年08月29日
発行: The Insight Partners
ページ情報: 英文 101 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 図表
  • 目次
概要

北米のバイオ医薬品向け凍結乾燥サービス市場は、2023年の9億7,405万米ドルから2028年には15億8,777万米ドルに成長すると予測されています。2023年から2028年までのCAGRは10.3%と推定されます。

凍結乾燥製品に対する需要の高まりが北米バイオ医薬品用凍結乾燥サービス市場を牽引

凍結乾燥は、保存期間と安定性を延長するために材料から水分を除去する凍結乾燥法です。凍結乾燥で処理された製品は高真空下で凍結され、高品質で手頃な価格の製品を製造するために製薬業界で主に使用されています。バイオテクノロジー由来の製品、体外診断薬、抗感染症薬など、多くの新しい非経口製品は凍結乾燥製品として製造されています。凍結乾燥工程では、セファロスポリン、半合成ペニシリン、エリスロマイシン塩、クロラムフェニコール、ドキシサイクリンなどの抗生物質が製造されます。抗生物質製剤をバッチ化する場合、生物負荷が低いことが期待されるが、これは凍結乾燥を用いることで達成できます。同様に、コハク酸メチルプレドニゾロンナトリウム、コハク酸ヒドロコルチゾンナトリウム、および多くのバイオテクノロジー由来の製品のような他のいくつかの剤形も凍結乾燥されています。

ここ数年、米国食品医薬品局（FDA）により毎年10種類以上の新規生物製剤が承認されています。FDAが2022年2月に発表したデータによると、生物製剤はFDAが承認した全医薬品の25％強を占め続けています。これらの製品のほとんどは水性製剤として安定ではないため、長期保存が課題となっています。そのため、乾燥バイオ医薬品製剤の製造には、より長く商業的に実行可能な保存期間を達成するために凍結乾燥が好まれています。ルーブリゾールライフサイエンスが発表したデータによると、2019年10月、市場における生物製剤生産の60％以上は凍結乾燥なしでは不可能であり、バイオシミラーや新規生物製剤の開発の増加により、凍結乾燥技術に対する市場の需要は増加します。この方法は、生物製剤の正確な投与量（例えば、非常に少量で高濃度の投与）を提供する一方で安定性に問題がある場合に有益です。さらに、熱、酸素、湿度に敏感な生物製剤にも適しています。さらに、凍結乾燥はバイオテクノロジー産業において重要なものとなってきており、複数のサプライヤーが凍結乾燥済み製品または凍結乾燥前製品をマーケットプレースに投入しています。その結果、凍結乾燥サービスへの需要が急速に高まり、バイオ医薬品向け凍結乾燥サービス市場の成長を牽引しています。

北米のバイオ医薬品向け凍結乾燥サービス市場の概要

北米のバイオ医薬品向け凍結乾燥サービス市場は、米国、カナダ、メキシコにさらに細分化されます。2022年の北米バイオ医薬品向け凍結乾燥サービス市場では、米国が最大のシェアを占めています。米国の市場成長は、広範な研究開発活動、革新的なバイオ医薬品や医薬品の高度な製造などの要因によるものです。同様に、カナダにおけるバイオ医薬品産業の著しい成長と国際企業による投資の増加は、市場の成長をより速いペースで加速させる可能性が高いです。米国、カナダ、メキシコにおけるバイオ医薬品産業の成長は、各国に雇用機会を生み出しています。

北米のバイオ医薬品向け凍結乾燥サービス市場の収益と2028年までの予測（金額）

北米のバイオ医薬品向け凍結乾燥サービス市場のセグメンテーション

北米のバイオ医薬品向け凍結乾燥サービス市場は、サービスタイプ、エンドユーザー、国に区分されます。

サービスタイプ別に見ると、北米のバイオ医薬品向け凍結乾燥サービス市場は、凍結乾燥サイクル開拓、臨床製造、商業製造、凍結乾燥分析サービスに区分されます。2023年の北米バイオ医薬品向け凍結乾燥サービス市場では、商業製造セグメントが最大のシェアを占めています。

エンドユーザーに基づき、北米のバイオ医薬品向け凍結乾燥サービス市場は製薬＆バイオテクノロジー企業、研究機関、その他に区分されます。2023年の北米バイオ医薬品向け凍結乾燥サービス市場では、製薬・バイオテクノロジー企業セグメントが最大のシェアを占めています。

国別に見ると、北米のバイオ医薬品向け凍結乾燥サービス市場は米国、カナダ、メキシコに区分されます。2023年の北米バイオ医薬品向け凍結乾燥サービスは米国が圧倒的なシェアを占めています。

ATTWILL Medical Solutions社、Axcellerate Pharma LLC社、Berkshire Sterile Manufacturing社、Curia Global Inc社、Emergent BioSolutions Inc社、Jubilant HollisterStier LLC社、Labyrinth BioPharma LLC社、Lyophilization Technology, Inc社、PCI Pharma Services社が北米バイオ医薬品向け凍結乾燥サービスの主要企業です。

目次

第1章 イントロダクション

第2章 北米バイオ医薬品向け凍結乾燥サービス市場-要点

第3章 調査手法

  • 調査範囲
  • 2次調査
  • 1次調査

第4章 バイオ医薬品向け凍結乾燥サービスの北米市場- 市場情勢

  • 北米PEST分析
  • 専門家の見解

第5章 バイオ医薬品向け凍結乾燥サービスの北米市場- 主要市場力学

  • 市場促進要因
    • 凍結乾燥製品に対する需要の高まり
    • 受託製造と凍結乾燥サービスの急成長
  • 市場抑制要因
    • 凍結乾燥プロセスに伴うデメリット
  • 市場機会
    • 高度な凍結乾燥技術の登場
  • 今後の動向
    • siRNAおよび抗体ベースの製剤数の増加
  • 促進要因と阻害要因の影響分析

第6章 バイオ医薬品向け凍結乾燥サービス市場-北米分析

  • 北米のバイオ医薬品向け凍結乾燥サービス市場の収益と予測分析

第7章 バイオ医薬品向け凍結乾燥サービスの北米市場分析と2028年までの予測-サービスタイプ別

  • 北米のバイオ医薬品向け凍結乾燥サービス市場：サービスタイプ別2022年・2028年（%）
  • 商業用製造
  • 臨床製造
  • 凍結乾燥サイクル開発
  • 凍結乾燥分析サービス

第8章 北米のバイオ医薬品向け凍結乾燥サービス市場の分析と2028年までの予測：エンドユーザー別

  • 北米のバイオ医薬品向け凍結乾燥サービス市場：エンドユーザー別2022年・2028年（%）
  • 製薬企業およびバイオテクノロジー企業
  • 研究機関
  • その他

第9章 北米のバイオ医薬品向け凍結乾燥サービス市場：収益と2028年までの予測：国別分析

第10章 バイオ医薬品向け凍結乾燥サービスの北米市場- 業界情勢

  • 北米のバイオ医薬品向け凍結乾燥サービス市場における成長戦略
  • 無機的成長戦略
  • 有機的成長戦略

第11章 企業プロファイル

  • ATTWILL Medical Solutions
  • Axcellerate Pharma LLC
  • Labyrinth BioPharma LLC
  • Berkshire Sterile Manufacturing
  • PCI Pharma Services
  • Curia Global Inc
  • Emergent BioSolutions Inc
  • Jubilant HollisterStier LLC.
  • Lyophilization Technology, Inc.

第12章 付録

図表

List Of Tables

  • Table 1. US North America Lyophilization Services for Biopharmaceuticals Market, by Service Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 2. US North America Lyophilization Services for Biopharmaceuticals Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 3. Canada North America Lyophilization Services for Biopharmaceuticals Market, by Service Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 4. Canada North America Lyophilization Services for Biopharmaceuticals Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 5. Mexico North America Lyophilization Services for Biopharmaceuticals Market, by Service Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 6. Mexico North America Lyophilization Services for Biopharmaceuticals Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 7. Recent Inorganic Growth Strategies in the North America Lyophilization Services for Biopharmaceuticals Market
  • Table 8. Recent Organic Growth Strategies in the North America Lyophilization Services for Biopharmaceuticals Market
  • Table 9. Glossary of Terms

List Of Figures

  • Figure 1. North America Lyophilization Services for Biopharmaceuticals Market Segmentation
  • Figure 2. North America Lyophilization Services for Biopharmaceuticals Market, by Country
  • Figure 3. North America Lyophilization Services for Biopharmaceuticals Market Overview
  • Figure 4. Commercial Manufacturing Segment Held Largest Share of Service Type Segment in North America Lyophilization Services for Biopharmaceuticals Market
  • Figure 5. The US Expected to Show Remarkable Growth During Forecast Period
  • Figure 6. North America: PEST Analysis
  • Figure 7. Experts' Opinion
  • Figure 8. North America Lyophilization Services for Biopharmaceuticals Market Impact Analysis of Drivers and Restraint
  • Figure 9. North America Lyophilization Services for Biopharmaceuticals Market - Revenue Forecast and Analysis - 2020-2028
  • Figure 10. North America Lyophilization Services for Biopharmaceuticals Market, by Service Type 2022 & 2028 (%)
  • Figure 11. Commercial Manufacturing: North America Lyophilization Services for Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 12. Clinical Manufacturing: North America Lyophilization Services for Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 13. Lyophilization Cycle Development: North America Lyophilization Services for Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 14. Freeze Drying Analytical Services: North America Lyophilization Services for Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 15. North America Lyophilization Services for Biopharmaceuticals Market, by End User, 2022 & 2028 (%)
  • Figure 16. Pharmaceutical and Biotechnology Companies: North America Lyophilization Services for Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 17. Research Institutes: North America Lyophilization Services for Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 18. Others: North America Lyophilization Services for Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 19. North America Lyophilization Services for Biopharmaceuticals Market, by Key Country - Revenue (2022) (US$ Million)
  • Figure 20. US: North America Lyophilization Services for Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 21. Canada: North America Lyophilization Services for Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 22. Mexico: North America Lyophilization Services for Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 23. Growth Strategies in the North America Lyophilization Services for Biopharmaceuticals Market
目次
Product Code: BMIRE00028842

The North America lyophilization services for biopharmaceuticals market is expected to grow from US$ 974.05 million in 2023 to US$ 1,587.77 million by 2028. It is estimated to register a CAGR of 10.3% from 2023 to 2028.

Rising Demand for Lyophilized Products Fuel North America Lyophilization Services for Biopharmaceuticals Market

Lyophilization is a freeze-drying method that removes water from the material to extend its shelf life and stability. The products processed under lyophilization are frozen under high vacuum and are majorly used in pharmaceutical industries to manufacture high-quality and affordable products. Many new parenteral products, including biotechnology-derived products, in-vitro diagnostics, and anti-infectives, are manufactured as lyophilized products. The lyophilization process makes antibiotics such as cephalosporins, semi-synthetic penicillin, erythromycin salts, chloramphenicol, and doxycycline. Low bioburden is expected when batching antibiotics formulations, which can be attained using lyophilization. Similarly, a few other dosage forms such as methylprednisolone sodium succinate, hydrocortisone sodium succinate, and many biotechnology-derived products are lyophilized.

Over 10 novel biologics have been approved annually by the US Food and Drug Administration (FDA) in the last few years. According to the data published by FDA in February 2022, biologics continue to account for slightly more than 25% of all drugs accepted by the FDA. Most of these products are not stable as aqueous formulations, making it challenging to preserve them for longer durations. Thus, lyophilization is preferred for making dry biopharmaceutical formulations to achieve longer and commercially viable shelf lives. According to the data published by Lubrizol Life Science, in October 2019, over 60% of biologics production in the market would not be possible without lyophilization, and market demand for lyophilization technology will increase due to the growing biosimilars and novel biologics development. The method proves beneficial when there is a stability issue while providing exact biologics dosage (for instance, very small and highly concentrated doses). Furthermore, it is suitable for biologics sensitive to heat, oxygen, and humidity. Further, lyophilization has become important in the biotech industry, as several suppliers are introducing lyo-ready or pre-lyophilized products to the marketplace. As a result, the demand for lyophilization services is growing rapidly, driving the growth of the lyophilization services for biopharmaceuticals market.

North America Lyophilization Services for Biopharmaceuticals Market Overview

The lyophilization services for biopharmaceuticals market in North America is further segmented into the US, Canada, and Mexico. The US held the largest share of the North America lyophilization services for biopharmaceuticals market in 2022. The market growth in the US is attributed to factors such as extensive research and development activities, advanced manufacturing of innovative biopharmaceutical and pharmaceutical products. Likewise, the significant growth of the biopharmaceutical industry in Canada and increasing investment by international companies are likely to accelerate the market growth at a faster pace. The growing biopharmaceutical industry in the US, Canada, and Mexico is generating job opportunities across the countries.

North America Lyophilization Services for Biopharmaceuticals Market Revenue and Forecast to 2028 (US$ Million)

North America Lyophilization Services for Biopharmaceuticals Market Segmentation

The North America lyophilization services for biopharmaceuticals market is segmented into service type, end user, and country.

Based on service type, the North America lyophilization services for biopharmaceuticals market is segmented into lyophilization cycle development, clinical manufacturing, commercial manufacturing, and freeze drying analytical services. The commercial manufacturing segment held the largest share of the North America lyophilization services for biopharmaceuticals market in 2023.

Based on end user, the North America lyophilization services for biopharmaceuticals market is segmented into pharmaceutical & biotechnology companies, research institutes, and others. The pharmaceutical & biotechnology companies segment held the largest share of the North America lyophilization services for biopharmaceuticals market in 2023.

Based on country, the North America lyophilization services for biopharmaceuticals market is segmented into the US, Canada, and Mexico. The US dominated the share of the North America lyophilization services for biopharmaceuticals market in 2023.

ATTWILL Medical Solutions; Axcellerate Pharma LLC; Berkshire Sterile Manufacturing; Curia Global Inc; Emergent BioSolutions Inc; Jubilant HollisterStier LLC.; Labyrinth BioPharma LLC; Lyophilization Technology, Inc.; and PCI Pharma Services are the leading companies operating in the North America lyophilization services for biopharmaceuticals market.

Reasons to Buy:

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the North America lyophilization services for biopharmaceuticals market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in North America lyophilization services for biopharmaceuticals market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth North America market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

Table Of Contents

1. Introduction

  • 1.1 Scope of the Study
  • 1.2 The Insight Partners Research Report Guidance
  • 1.3 Market Segmentation
    • 1.3.1 North America Lyophilization Services for Biopharmaceuticals Market - by Service Type
    • 1.3.2 North America Lyophilization Services for Biopharmaceuticals Market - by End User
    • 1.3.3 North America Lyophilization Services for Biopharmaceuticals Market - by Country

2. North America Lyophilization Services for Biopharmaceuticals Market - Key Takeaways

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. North America Lyophilization Services for Biopharmaceuticals Market - Market Landscape

  • 4.1 Overview
  • 4.2 North America PEST Analysis
  • 4.3 Expert's Opinion

5. North America Lyophilization Services for Biopharmaceuticals Market - Key Market Dynamics

  • 5.1 Market Driver
    • 5.1.1 Rising Demand for Lyophilized Products
    • 5.1.2 Rapid Growth in Contract Manufacturing and Lyophilization Services
  • 5.2 Market Restraints
    • 5.2.1 Demerits Associated with Lyophilization Process
  • 5.3 Market Opportunities
    • 5.3.1 Launch of Advanced Lyophilization Technology
  • 5.4 Future Trends
    • 5.4.1 Growing Number of siRNA and Antibody-Based Formulations
  • 5.5 Impact Analysis of Drivers and Restraints

6. Lyophilization Services for Biopharmaceuticals Market - North America Analysis

  • 6.1 North America Lyophilization Services for Biopharmaceuticals Market Revenue Forecast and Analysis

7. North America Lyophilization Services for Biopharmaceuticals Market Analysis and Forecast to 2028 - by Service Type

  • 7.1 Overview
  • 7.2 North America Lyophilization Services for Biopharmaceuticals Market, by Service Type 2022 & 2028 (%)
  • 7.3 Commercial Manufacturing
    • 7.3.1 Overview
    • 7.3.2 Commercial Manufacturing: North America Lyophilization Services for Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
  • 7.4 Clinical Manufacturing
    • 7.4.1 Overview
    • 7.4.2 Clinical Manufacturing: North America Lyophilization Services for Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
  • 7.5 Lyophilization Cycle Development
    • 7.5.1 Overview
    • 7.5.2 Lyophilization Cycle Development: North America Lyophilization Services for Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
  • 7.6 Freeze Drying Analytical Services
    • 7.6.1 Overview
    • 7.6.2 Freeze Drying Analytical Services: North America Lyophilization Services for Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)

8. North America Lyophilization Services for Biopharmaceuticals Market Analysis and Forecast to 2028 - by End User

  • 8.1 Overview
  • 8.2 North America Lyophilization Services for Biopharmaceuticals Market, by End User, 2022 & 2028 (%)
  • 8.3 Pharmaceutical and Biotechnology Companies
    • 8.3.1 Overview
    • 8.3.2 Pharmaceutical and Biotechnology Companies: North America Lyophilization Services for Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
  • 8.4 Research Institutes
    • 8.4.1 Overview
    • 8.4.2 Research Institutes: North America Lyophilization Services for Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
  • 8.5 Others
    • 8.5.1 Overview
    • 8.5.2 Others: North America Lyophilization Services for Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)

9. North America Lyophilization Services for Biopharmaceuticals Market - Revenue and Forecast to 2028 -Country Analysis

  • 9.1 Overview
    • 9.1.1 North America Lyophilization Services for Biopharmaceuticals Market, by Country, 2022 & 2028 (%)
      • 9.1.1.1 US: North America Lyophilization Services for Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
        • 9.1.1.1.1 Overview
        • 9.1.1.1.2 US: North America Lyophilization Services for Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
        • 9.1.1.1.3 US: North America Lyophilization Services for Biopharmaceuticals Market, by Service Type, 2020-2028 (US$ Million)
        • 9.1.1.1.4 US North America Lyophilization Services for Biopharmaceuticals Market, by End User, 2020-2028 (US$ Million)
      • 9.1.1.2 Canada: North America Lyophilization Services for Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
        • 9.1.1.2.1 Overview
        • 9.1.1.2.2 Canada: North America Lyophilization Services for Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
        • 9.1.1.2.3 Canada: North America Lyophilization Services for Biopharmaceuticals Market, by Service Type, 2020-2028 (US$ Million)
        • 9.1.1.2.4 Canada: North America Lyophilization Services for Biopharmaceuticals Market, by End User, 2020-2028 (US$ Million)
      • 9.1.1.3 Mexico: North America Lyophilization Services for Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
        • 9.1.1.3.1 Overview
        • 9.1.1.3.2 Mexico: North America Lyophilization Services for Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
        • 9.1.1.3.3 Mexico: North America Lyophilization Services for Biopharmaceuticals Market, by Service Type, 2020-2028 (US$ Million)
        • 9.1.1.3.4 Mexico: North America Lyophilization Services for Biopharmaceuticals Market, by End User, 2020-2028 (US$ Million)

10. North America Lyophilization Services for Biopharmaceuticals Market - Industry Landscape

  • 10.1 Overview
  • 10.2 Growth Strategies in the North America Lyophilization Services for Biopharmaceuticals Market
  • 10.3 Inorganic Growth Strategies
    • 10.3.1 Overview
  • 10.4 Organic Growth Strategies
    • 10.4.1 Overview

11. Company Profiles

  • 11.1 ATTWILL Medical Solutions
    • 11.1.1 Key Facts
    • 11.1.2 Business Description
    • 11.1.3 Products and Services
    • 11.1.4 Financial Overview
    • 11.1.5 SWOT Analysis
    • 11.1.6 Key Developments
  • 11.2 Axcellerate Pharma LLC
    • 11.2.1 Key Facts
    • 11.2.2 Business Description
    • 11.2.3 Products and Services
    • 11.2.4 Financial Overview
    • 11.2.5 SWOT Analysis
    • 11.2.6 Key Developments
  • 11.3 Labyrinth BioPharma LLC
    • 11.3.1 Key Facts
    • 11.3.2 Business Description
    • 11.3.3 Products and Services
    • 11.3.4 Financial Overview
    • 11.3.5 SWOT Analysis
    • 11.3.6 Key Developments
  • 11.4 Berkshire Sterile Manufacturing
    • 11.4.1 Key Facts
    • 11.4.2 Business Description
    • 11.4.3 Products and Services
    • 11.4.4 Financial Overview
    • 11.4.5 SWOT Analysis
    • 11.4.6 Key Developments
  • 11.5 PCI Pharma Services
    • 11.5.1 Key Facts
    • 11.5.2 Business Description
    • 11.5.3 Products and Services
    • 11.5.4 Financial Overview
    • 11.5.5 SWOT Analysis
    • 11.5.6 Key Developments
  • 11.6 Curia Global Inc
    • 11.6.1 Key Facts
    • 11.6.2 Business Description
    • 11.6.3 Products and Services
    • 11.6.4 Financial Overview
    • 11.6.5 SWOT Analysis
    • 11.6.6 Key Developments
  • 11.7 Emergent BioSolutions Inc
    • 11.7.1 Key Facts
    • 11.7.2 Business Description
    • 11.7.3 Products and Services
    • 11.7.4 Financial Overview
    • 11.7.5 SWOT Analysis
    • 11.7.6 Key Developments
  • 11.8 Jubilant HollisterStier LLC.
    • 11.8.1 Key Facts
    • 11.8.2 Business Description
    • 11.8.3 Products and Services
    • 11.8.4 Financial Overview
    • 11.8.5 SWOT Analysis
    • 11.8.6 Key Developments
  • 11.9 Lyophilization Technology, Inc.
    • 11.9.1 Key Facts
    • 11.9.2 Business Description
    • 11.9.3 Products and Services
    • 11.9.4 Financial Overview
    • 11.9.5 SWOT Analysis
    • 11.9.6 Key Developments

12. Appendix

  • 12.1 About The Insight Partners
  • 12.2 Glossary of Terms